Dr Reddy’s Laboratories shares extended their decline after the company delayed commercial supplies of its semaglutide product due to a quality-related API issue. While brokerages remain broadly positive on the long-term outlook, several have cut target prices and earnings estimates, citing near-term execution risks and slower product ramp-up.
Indian stock markets deliver negative returns for two years, worst since 2012, ET analysis reveals
Indian stock markets have disappointed investors with negative returns over two years. The Sensex has shown its worst two-year performance since 2012. Indices have not
August 25, 2026